CAS: 1374325-56-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid REF: 3D-ZEC32556CAS: 1374325-56-0 | Min. 95% | A consultar | Jue 08 May 25 |
 | C3001a REF: TM-T71955CAS: 1374325-56-0 | - - - | 1.444,00 €~2.375,00 € | Jue 15 May 25 |
![3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid](https://static.cymitquimica.com/products/3D/thumb/ZEC32556.jpg)
3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid
CAS:1374325-56-0
3-((4-(6-Methylbenzo[D]thiazol-2-yl)phenyl)carbamoyl)cyclopentanecarboxylic acid is a biologically active compound that belongs to the class of inhibitors. It …
Fórmula:
C21H20N2O3S
Pureza:
Min. 95%
Peso molecular:
380.5 g/mol
Ref: 3D-ZEC32556
| 25mg | 1.040,00 € | ||
| 50mg | 1.447,00 € |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025
C3001a
CAS:1374325-56-0
C3001a selectively activates TREK channels, reducing pain and inflammation without opioid side effects.
Fórmula:
C21H20N2O3S
Forma y color:
Liquid
Peso molecular:
380.46
Ref: TM-T71955
| 25mg | 1.444,00 € | ||
| 50mg | 1.882,00 € | ||
| 100mg | 2.375,00 € |
Entrega estimada en Estados Unidos, el Jueves 15 de Mayo de 2025
